{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:50:13Z","timestamp":1780476613667,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-024-00253-x","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T09:12:32Z","timestamp":1723194752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia"],"prefix":"10.1186","volume":"10","author":[{"given":"Steve","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Nagraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Ferrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"3","key":"253_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0268-960X(94)90072-P","volume":"8","author":"SJ Wright","year":"1994","unstructured":"Wright SJ, Robertson LE, O\u2019Brien S, Plunkett W, Keating MJ. The role of fludarabine in hematological malignancies. Blood Rev. 1994;8(3):125\u201334.","journal-title":"Blood Rev"},{"issue":"9","key":"253_CR2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.leukres.2013.05.004","volume":"37","author":"J Lukenbill","year":"2013","unstructured":"Lukenbill J, Kalaycio M. Fludarabine: a review of the clear benefits and potential harms. Leuk Res. 2013;37(9):986\u201394.","journal-title":"Leuk Res"},{"issue":"18","key":"253_CR3","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1200\/JCO.2005.12.051","volume":"23","author":"MJ Keating","year":"2005","unstructured":"Keating MJ, O\u2019Brien S, Albitar M, Lerner S, Plunkett W, Giles F, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol. 2005;23(18):4079\u201388.","journal-title":"J Clin Oncol"},{"issue":"3","key":"253_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jccase.2019.05.001","volume":"20","author":"G Newbery","year":"2019","unstructured":"Newbery G, Lima NA, Gurgel LA, Driscoll R, Lima CCV. Persistent heart failure following melphalan and fludarabine conditioning. J Cardiol Cases. 2019;20(3):88\u201391.","journal-title":"J Cardiol Cases"},{"issue":"1","key":"253_CR5","first-page":"59","volume":"8","author":"M Florescu","year":"2013","unstructured":"Florescu M, Cinteza M, Vinereanu D. Chemotherapy-induced Cardiotoxicity. Maedica (Bucur). 2013;8(1):59\u201367.","journal-title":"Maedica (Bucur)"},{"issue":"1","key":"253_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","volume":"28","author":"DS Ritchie","year":"2001","unstructured":"Ritchie DS, Seymour JF, Roberts AW, Szer J, Grigg AP. Acute left ventricular failure following melphalan and fludarabine conditioning. Bone Marrow Transplant. 2001;28(1):101\u20133.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"253_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/bmt.2009.97","volume":"45","author":"E Peres","year":"2010","unstructured":"Peres E, Levine JE, Khaled YA, Ibrahim RB, Braun TM, Krijanovski OI, et al. Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45(1):149\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"253_CR8","doi-asserted-by":"crossref","unstructured":"\u00c7elik S, G\u00fcven ZT, Alt\u0131nsoy A, Tubay \u015e, Keklik M, \u00dcnal A. Fludarabine-induced bradycardia in allogeneic hematopoietic stem cell transplantation: A retrospective study. J Oncol Pharm Pract. 2023:10781552231189868.","DOI":"10.1016\/j.htct.2024.04.010"},{"issue":"2","key":"253_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1658-3876(10)50043-8","volume":"3","author":"W Chung-Lo","year":"2010","unstructured":"Chung-Lo W, Hsieh CY, Chiu CF, Bai LY. Fludarabine-induced bradycardia in a patient with refractory leukemia. Hematol Oncol Stem Cell Ther. 2010;3(2):99\u2013100.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"4","key":"253_CR10","doi-asserted-by":"publisher","first-page":"e12534","DOI":"10.1111\/anec.12534","volume":"23","author":"M Por\u0119ba","year":"2018","unstructured":"Por\u0119ba M, Ga\u0107 P, Usnarska-Zubkiewicz L, Pilecki W, Kuliczkowski K, Mazur G, et al. The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation. Ann Noninvasive Electrocardiol. 2018;23(4):e12534.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"24","key":"253_CR11","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"253_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cpcardiol.2008.01.002","volume":"33","author":"SW Yusuf","year":"2008","unstructured":"Yusuf SW, Razeghi P, Yeh ET. The diagnosis and management of cardiovascular disease in cancer patients. Curr Probl Cardiol. 2008;33(4):163\u201396.","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"253_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/0003-4819-111-4-273","volume":"111","author":"WP McGuire","year":"1989","unstructured":"McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 1989;111(4):273\u20139.","journal-title":"Ann Intern Med"},{"issue":"9","key":"253_CR14","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1200\/JCO.1991.9.9.1704","volume":"9","author":"EK Rowinsky","year":"1991","unstructured":"Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC. Cardiac disturbances during the administration of taxol. J Clin Oncol. 1991;9(9):1704\u201312.","journal-title":"J Clin Oncol"},{"key":"253_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fnins.2014.00402","volume":"8","author":"F Chouchou","year":"2014","unstructured":"Chouchou F, Desseilles M. Heart rate variability: a tool to explore the sleeping brain? Front Neurosci. 2014;8:402.","journal-title":"Front Neurosci"},{"issue":"5","key":"253_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1097\/00000539-200111000-00044","volume":"93","author":"MK Loushin","year":"2001","unstructured":"Loushin MK, Hasinoff IK, Belani KG. A delayed cardiopulmonary reaction to an intravenous immunosuppressant thymoglobulin after pancreas transplant. Anesth Analg. 2001;93(5):1260\u20131 table of contents.","journal-title":"Anesth Analg"},{"issue":"5","key":"253_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2141.2008.07389.x","volume":"143","author":"SY Kao","year":"2008","unstructured":"Kao SY, Xu W, Brandwein JM, Lipton JH, Messner HA, Minden MD, et al. Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy. Br J Haematol. 2008;143(5):738\u201343.","journal-title":"Br J Haematol"},{"issue":"3","key":"253_CR18","first-page":"218","volume":"16","author":"J Godown","year":"2011","unstructured":"Godown J, Deal AM, Riley K, Bailliard F, Blatt J. Worsening bradycardia following antithymocyte globulin treatment of severe aplastic anemia. J Pediatr Pharmacol Ther. 2011;16(3):218\u201321.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"2","key":"253_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.htct.2020.08.018","volume":"44","author":"S Elazhary","year":"2022","unstructured":"Elazhary S, Alawyat HA. Bradycardia associated with antithymocyte globulin treatment of a pediatric patient with sickle cell disease: a case report and literature review. Hematol Transfus Cell Ther. 2022;44(2):284\u20137.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"253_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12253-018-0403-y","volume":"25","author":"K K\u00e1llay","year":"2019","unstructured":"K\u00e1llay K, Zakari\u00e1s D, Csord\u00e1s K, Beny\u00f3 G, Kassa C, Sink\u00f3 J, et al. Antithymocyte Globuline Therapy and Bradycardia in Children. Pathol Oncol Res. 2019;25(2):487\u201392.","journal-title":"Pathol Oncol Res"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-024-00253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-024-00253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-024-00253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T20:34:25Z","timestamp":1723235665000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-024-00253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1186\/s40959-024-00253-x","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided consent and gave permission to have her case, as well as relevant related workup and diagnostic images, presented in the medical literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}